Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomy.


Journal

Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 26 03 2021
accepted: 01 06 2021
pubmed: 17 6 2021
medline: 31 3 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

To evaluate potential factors associated with the risk of perioperative blood transfusion (PBT) with implications on length of hospital stay (LOHS) and major post-operative complications in patients who underwent robot-assisted radical prostatectomy (RARP) as a primary treatment for prostate cancer (PCa). In a period ranging from January 2013 to August 2019, 980 consecutive patients who underwent RARP were retrospectively evaluated. Clinical factors such as intraoperative blood loss were evaluated. The association of factors with the risk of PBT was investigated by statistical methods. Overall, PBT was necessary in 39 patients (4%) in whom four were intraoperatively. Positive surgical margins, operating time and intraoperative blood loss were associated with perioperative blood transfusion on univariate analysis. On multivariate analysis, the risk of PBT was predicted by intraoperative blood loss (odds ratio, OR 1.002; 95% CI 1.001-1.002; p < 0.0001), which was associated with prolonged operating time and elevated body mass index (BMI). PBT was associated with delayed LOHS and Clavien-Dindo complications > 2. In patients undergoing RARP as a primary treatment for PCa, the risk of PBT represented a rare event that was predicted by severe intraoperative bleeding, which was associated with increased BMI as well as with prolonged operating time. In patients who received a PBT, prolonged LOHS as well as an elevated risk of major Clavien-Dindo complications were seen.

Identifiants

pubmed: 34131882
doi: 10.1007/s11701-021-01262-z
pii: 10.1007/s11701-021-01262-z
pmc: PMC8960588
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-471

Informations de copyright

© 2021. The Author(s).

Références

Mottet N et al. (2018) EAU—ESTRO-SIOG guidelines on prostate cancer. 2016
Mohler JL et al (2019) Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17(5):479–505
doi: 10.6004/jnccn.2019.0023
Porcaro AB et al (2016) Robotic assisted radical prostatectomy accelerates postoperative stress recovery: final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery. Asian J Urol 3(2):88–95
doi: 10.1016/j.ajur.2016.03.002
Mitropoulos D et al (2013) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Actas Urológicas Españolas 37(1):1–11
doi: 10.1016/j.acuro.2012.02.002
Menon M, Tewari A, Peabody J (2003) Vattikuti institute prostatectomy: technique. J Urol 169(6):2289–2292
doi: 10.1097/01.ju.0000067464.53313.dd
Ou YC et al (2011) The learning curve for reducing complications of robotic-assisted laparoscopic radical prostatectomy by a single surgeon. BJU Int 108(3):420–425
doi: 10.1111/j.1464-410X.2010.09847.x
Porcaro AB et al (2017) Clinical factors of disease reclassification or progression in a contemporary cohort of prostate cancer patients elected to active surveillance. Urol Int 98(1):32–39
doi: 10.1159/000452631
Porcaro AB et al (2016) Low-risk prostate cancer and tumor upgrading to higher patterns in the surgical specimen. Analysis of clinical factors predicting tumor upgrading to higher Gleason patterns in a contemporary series of patients who have been evaluated according to the modified Gleason score grading system. Urol Int 97(1):32–41
doi: 10.1159/000445034
Porcaro AB et al (2018) Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer. Tumori 104(2):111–115
doi: 10.5301/tj.5000580
Porcaro AB et al (2019) Lymph nodes invasion of Marcille’s fossa associates with high metastatic load in prostate cancer patients undergoing extended pelvic lymph node dissection: The role of “marcillectomy.” Urol Int. https://doi.org/10.1159/000500330
doi: 10.1159/000500330 pubmed: 31466070
Cacciamani GE et al (2019) Extended pelvic lymphadenectomy for prostate cancer: should the Cloquet’s nodes dissection be considered only an option? Minerva Urol Nefrol 71(2):136–145
doi: 10.23736/S0393-2249.19.03342-3
Pierorazio PM et al (2013) Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 111(5):753–760
doi: 10.1111/j.1464-410X.2012.11611.x
Epstein JI et al (2016) A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol 69(3):428–435
doi: 10.1016/j.eururo.2015.06.046
Dripps RD, Lamont A, Eckenhoff JE (1961) The role of anesthesia in surgical mortality. JAMA 178:261–266
doi: 10.1001/jama.1961.03040420001001
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205
doi: 10.1097/01.sla.0000133083.54934.ae
World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. Technical report series 854: 1–452
Coelho RF et al (2010) Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 24(12):2003–2015
doi: 10.1089/end.2010.0295
Pilecki MA et al (2014) National multi-institutional comparison of 30-day postoperative complication and readmission rates between open retropubic radical prostatectomy and robot-assisted laparoscopic prostatectomy using NSQIP. J Endourol 28(4):430–436
doi: 10.1089/end.2013.0656
Xia L et al (2017) Predischarge predictors of readmissions and postdischarge complications in robot-assisted radical prostatectomy. J Endourol 31(9):864–871
doi: 10.1089/end.2017.0293
Pereira JF et al (2018) The association of age with perioperative morbidity and mortality among men undergoing radical prostatectomy. Urol Oncol 36(4):157.e7-157.e13
doi: 10.1016/j.urolonc.2017.11.019
Brito J 3rd et al (2018) The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer Prostatic Dis 21(2):245–251
doi: 10.1038/s41391-018-0051-z
Leow JJ et al (2016) Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database. Eur Urol 70(5):837–845
doi: 10.1016/j.eururo.2016.01.044
Porcaro AB et al (2019) Is a drain needed after robotic radical prostatectomy with or without pelvic lymph node dissection? Results of a single-center randomized clinical trial. J Endourol. https://doi.org/10.1089/end.2018.0176
doi: 10.1089/end.2018.0176 pubmed: 30484332
Wallerstedt Lantz A et al (2019) 90-day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery. Scand J Urol 53(1):26–33
doi: 10.1080/21681805.2018.1556729
Porcaro A et al (2019) Body mass index and prostatic specific antigen are independent predictors of multiple prostate cancer lymph node metastases in Caucasian patients undergoing robot assisted radical prostatectomy and extended pelvic lymph node dissection. Minerva Urol Nefrol 71(5):516–523
doi: 10.23736/S0393-2249.19.03401-5
Tafuri A et al (2020) Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection. Int Urol Nephrol 52(11):2097–2105
doi: 10.1007/s11255-020-02554-3
Antonelli A et al (2019) Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial. J Robot Surg 13(2):253–260
doi: 10.1007/s11701-018-0847-9
Porcaro AB et al (2020) High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection. Asian J Androl 22(3):323
doi: 10.4103/aja.aja_70_19
Porcaro AB et al (2019) Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection. J Robot Surg 13(1):83–89
doi: 10.1007/s11701-018-0824-3

Auteurs

Antonio Benito Porcaro (AB)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy. drporcaro@yahoo.com.

Riccardo Rizzetto (R)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Nelia Amigoni (N)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Alessandro Tafuri (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy. tafuri.alessandro@gmail.com.
Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University, Chieti, Italy. tafuri.alessandro@gmail.com.

Aliasger Shakir (A)

USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA.

Leone Tiso (L)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Clara Cerrato (C)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Stefano Zecchini Antoniolli (SZ)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Vincenzo Lacola (V)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Alessandra Gozzo (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Katia Odorizzi (K)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Rossella Orlando (R)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Giacomo Di Filippo (G)

Department of General and Hepatobiliary Surgery, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.

Matteo Brunelli (M)

Department of Pathology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.

Filippo Migliorini (F)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Vincenzo De Marco (V)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Walter Artibani (W)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Maria Angela Cerruto (MA)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Alessandro Antonelli (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale Stefani, 137126, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH